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Abstract
Background: Omega3 polyunsaturated fatty acids (PUFAs) are related to several diseases, including smoking. The aim
of this study was to evaluate the relationship between omega-3 intake and tobacco smoking, taking into account the
qualitative differences in dietary intake between smokers and non-smokers, the amount of the ingested PUFA and
their red blood (RBC) contents. We also looked for an association between omega-3 RBC content and smoking, and
also between omega3 intake and the level of nicotine dependence.
Methods: Using a cross-sectional study, we included 50 current smokers (group I) and 50 lifetime non-smokers (group
II), aged 18–75 years. We screened them at the Toronto Western Hospital and the Centre for Addiction and Mental
Health (Toronto, Canada). The subjects completed a questionnaire with demographic data, lifestyle habits and details
of food intake. The PUFAs measured in the RBC membranes were alphalinolenic acid, eicosapentaenoic acid (EPA),
docosapentaenoic acid and docosahexaenoic acid (DHA). In order to perform an adjusted comparison between
smokers and non-smokers we used the ANCOVA model.
Results: After adjusting for confounding factors, non-smokers showed higher consumption of PUFAs, especially
salmon: 800 g (0–7.740) than smokers 430 g (0–2.150) P < 0.001. They also had higher DHA levels compared to
smokers: 4.81 % (2.79–10.21) and 4.13 % (2.33–7.73), respectively, p < 0.05. The other PUFAs showed no significant
differences between the two groups.
Conclusions: Smokers ate less fish rich in omega3 fatty acids than non-smokers, showing and inverse and significant
relationship between omega3 intake and smoking. Smokers had lower levels of DHA and EPA, a not previously
reported finding. Considering that PUFAs probably interfere in smoking habit, the increase in omega-3 consumption
may become a perspective in prevention or treatment of smoking. However, this inference must be evaluated through
specific studies.
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Background
The omega-3 fatty acids are important components of cell
membranes and have a role in numerous human meta-
bolic processes [1]. These substances may contribute to
the prevention and treatment of neurological [2, 3] and
cardiovascular diseases [4–6], many chronic inflammatory
and respiratory diseases [7–10], several of which are also
linked to tobacco smoking [11–13].
Omega-3 intake has been linked to positive effects on
brain functioning, affecting multiple processes in neuro-
transmitter pathways, synaptic transmission, membrane
permeability and signal transduction [14, 15].. On the
other hand, low levels are related to several neuro-
psychiatric diseases such as attention deficit hyperactivity
disorder, depression, schizophrenia [16–19], Alzheimer’s
disease [2].
Smoking may affect omega-3 levels and PUFAs (Polyun-
saturated Fatty Acids) are also considered to have a role
also in tobacco addiction. Such dual interference is related
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to various mechanisms. [17] Smoking can increase the
lipid peroxidation of PUFAs by promoting oxidative stress
[20, 21]. Another possibility is that tobacco smoke may
affect the synthesis and metabolism of fatty acids, and thus
modifying the omega-3 levels. Smoking may also be asso-
ciated with a reduced dietary intake of omega-3 due to
unhealthy lifestyle, including changes in dietary food
choices associated. A taste change among smokers is also
another possibility [6, 18–20]. However, differences in
omega-3 dietary intake between smokers and non-
smokers have not been fully studied, and the relationships
have not been thoroughly analyzed [6, 11, 15, 18–23].
Despite the importance of these substances in the hu-
man diet, there is no consensus in the literature regarding
optimal omega-3 levels. The omega-3 index is considered
a marker of PUFA status. It represents the sum of the per-
centages of eicosapentaenoic (EPA) and docosahexaenoic
(DHA) acids measured in the red blood cell membrane
(RBC). It is expressed as a percentage of total erythrocyte
fatty acids content. The recommended value of 8 % or
greater of the total PUFAs probably prevents coronary
heart disease in Western populations. However, if the
index value is lower than 4 %, there is an increased risk of
mortality due to cardiovascular events [24, 25]. Its role
has not been studied in other diseases.
Moreover, there is initial evidence that the usual diet
of smokers and non-smokers is different, especially in
relation to the consumption of fish and other foods rich
in omega-3 [6, 18, 20, 26].
Therefore, we decided to study the relationship between
smoking and possible qualitative differences in dietary in-
take between smokers and non-smokers, especially con-
sumption of omega-3, taking into account the source and
the amount of food ingested. The objective was to evalu-
ate the relationship between the intake of foods rich in
omega-3 among smoker and nonsmoker volunteers. In
addition, we searched for an association between RBC
omega-3 content and smoking load history and the level
of nicotine dependence.
Results
We screened 112 patients, but 6 subjects in each group
did not satisfy all the selection criteria (6 due to be using
omega-3 supplements, 3 due currently unstable diseases,
2 due a strict vegetarian diet and 1 due inability to
understand the study procedures). Therefore, we in-
cluded 50 volunteers in each group (smokers-group I
and nonsmokers-group II).
Table 1 presents the basic characteristics and habits of
the included subjects. Smokers were older than non-
smokers (53.0 ± 13.3 years vs. 40.2 ± 13.6 years, respectively;
P < 0.001) and had a significantly higher BMI than non-
smokers (27.2 ± 5.4 kg/m2 vs. 24.2 ± 3.7 kg/m2, respectively;
P = 0.002). There were no significant differences between
the two groups in gender, education level, regular physical
activity or weekly alcohol consumption.
The median (minimum and maximum) monthly con-
sumption of fish was significantly lower in smokers than
in non-smokers: 430 g (0–2.150) vs. 800 g (0–7.740),
respectively; P < 0.001.
Group I subjects smoked a mean (± SD) of 33.8 ± 30
pack-years and had a nicotine dependence of 5,36
(±2,97), according to the Fagerstrom test for nicotine de-
pendence (FTND) [27].
Table 2 presents the percentage (%) of each omega-3
fatty acid in the RBC membranes measured in this study
in relation to the total fatty acid content. The values repre-
sent the medians (minimum to maximum values). Only
DHA was significantly different in the two groups, being
4.13 % (2.33–7.73) and 4.81 % (2.79–10.21), P = 0.005 for
smokers and non-smokers, respectively. In all the
remaining PUFAs assessed (alpha-linolenic, eicosapenta-
enoic, docosahexaenoic acids) no significant differences
between groups were detected.
To evaluate the relationship between fish intake by
month and smoking, we carried out univariate and
multivariate analyses, as shown in Table 3. In the univar-
iate analysis, the geometric mean ratio (GMR) between
non-smokers and smokers was 2.16 (95 % CI: 1.36–






Age, years 53.0 (±13.3) 40.2 (±13.6) <0.001*
Female sex, no (%) 25 (50.0) 31 (62.0) 0.31#
Education≥ 9 years,
no. (%)
36 (72.0) 39 (78.0) 0.65#
BMI, kg/m2 27.2 (±5.4) 24.2 (±3.7) <0.002*
Physical activity, no
sessions/week
0.0 (0 to 7) 2.3 (0 to 7) 0.81’
Food consumption,
grams/month
Fish 430 (0 to 2150) 800 (0 to 7740) <0.001’
Shrimp 50 (0 to 1290) 100 (0 to 1500) 0.13’
Squid 0.0 (0 to 100) 0.0 (0 to 875) 0.11’
Sushi 0.0 (0 to 1720) 100 (0 to 2500) 0.060’
Flaxseed 0.0 (0 to 172) 0.0 (0 to 194) 0.68’
Walnuts 0.0 (0 to 455) 0.0 (0 to 645) 0.33’
Other nuts 25 (0 to 4515) 129 (0 to 8600) 0.13’
Granola 0.0 (0 to 1505) 0.0 (0 to 6020) 0.96’
Alcohol consumption 130 (407 to 1050) 136 (407 to 568) 0.34’
Pack-years 33.8 (±30) - -
Nicotine dependence
(Fagerstrom test)
5.36 (±2,97) - -
Data are presented as counts (percentages), mean (±SD) or median (minimum
to maximum)
*Student’s t test; #chi-square test; ’Mann-Whitney U test
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3.45); P = 0.001, η2 = 0.10. After adjusting for possible
confounding factors such as age, gender, education,
BMI, consumption of other foods and alcohol and phys-
ical activity, the GMR changed to 2.03 (95 % CI 1.09–
3.78); P = 0.026 and η2 = 0.07.
There was a significant difference in the consumption of
fish among the participants of the two groups. Regular in-
take of salmon was reported by 28 % of the smokers and
by 52 % of the non-smokers (P = 0.025). The difference in
consumption of the other types of fish was not signifi-
cantly different between the groups (Table 4).
The relationship between monthly fish intake and smok-
ing load was not significant, using pack-years as a marker.
The correlation coefficient was rs = 0.05; P = 0.74. Like-
wise, the relationship between monthly fish intake and
levels of nicotine dependence according to the FTND was
also not statistically significant. The correlation coefficient
was rs = 0.01; P = 0.98.
Discussion
In this study, we report that non-smokers consumed
significantly more fish than smokers, especially salmon.
They also had significantly higher DHA concentrations.
These results remained significant after adjusting for
possible confounding factors.
The role of omega-3 in smoking addiction has been
previously shown by the lower omega-3 fatty acids levels
among smokers [6, 7, 21, 28]. Also, the dietary supple-
mentation of these substances has been reported as
reducing tobacco cravings in regular smokers comparing
with placebo treatments [11].
However, most of these studies did not take into account
possible qualitative differences in dietary intake between
smokers and non-smokers. Our analysis of food
consumption was done assessing the feeding routine in
details for each participant. We observed that non-
smokers consumed significantly more salmon than
smokers, a difference not seen in the intake of other fish
species here studied. This finding is consistent with the
higher concentrations of RBC omega-3 detected in non-
smokers as the amounts of EPA and DHA in salmon are
recognized to be very high.
There was no significant difference in the intake of
other foods rich in alpha-linolenic acid, as shrimp, squid,
sushi, flaxseed, nuts, oilseeds and granola. We speculate
that these foods are typically consumed in smaller quan-
tities and less frequently.
There are several possible explanations for the lower
omega-3 content in smokers. Differences in eating choices
may be a consequence of changes in the taste of foods
caused by existing substances in cigarette smoke. Geo-
graphical and cultural patterns could induce a routinely
different intake of foods rich in omega-3. A dietary defi-
ciency of omega-3 may be associated with an increased
risk of smoking [13].
The role of the food chain in the intricate neurobiological
mechanisms related to the release of many neurotransmit-
ters in the brain, including those related to smoking still
needs to be further assessed [15, 22, 29–31]. However, it is
possible that the release of specific neurotransmitters,
particularly those from the dopaminergic route, caused by
smoking or diet choices might interfere with food alterna-
tives or even inducing the smoking habit [15, 31].. The low
omega-3 intake could be either a risk factor for or a
consequence of tobacco use [14, 15, 26]. Furthermore, the
supplementation of omega-3 in these subjects may result
in the renormalization of the dopaminergic system and also
reducing the negative symptoms of nicotine withdrawal,
but this perspective needs to be further studied.
Another possibility to explain the lower omega-3 con-
tent among smokers might be related to the metabolism
of these substances. The interference of smoking with
the absorption, metabolism and synthesis of fatty acids
is a possibility that should be considered [28]. Also, it is
known that PUFAs are susceptible to oxidation and
cigarette smoke has a potent oxidant role, another
proposed explanation for these findings [6, 19].
The effect of DHA in neural plasticity and in cognition
mechanisms is becoming clearer. There is evidence that
Table 2 RBC membrane omega-3 fatty acids percentage in subjects of the sample
Acid Coding Fatty acid nomenclature Smokers n = 50 Nonsmokers n = 50 P
18:3 Alpha-linolenic 0.32 (0.00 to 0.85) 0.26 (0.00 to 0.66) 0.43
20:5 Eicosapentaenoic 0.95 (0.35 to 2.24) 1.06 (0.13 to 2.93) 0.40
22:5 Docosapentaenoic 2.29 (1.43 to 3.45) 2.26 (1.64 to 3.17) 0.71
22:6 Docosahexaenoic 4.13 (2.33 to 7.73) 4.81 (2.79 to 10.21) 0.005
Data presented as median (minimum to maximum); measurement unit as the percentage (%) of each acid related to the total fatty acids. RBC red blood cell
Table 3 Fish consumption: Geometric Mean Ratio between
smokers and nonsmokers about (in grams per month)
Model Smokers Nonsmokers GMR 95 % CI P η2
n = 50 N = 50
Unadjusted 276 598 2.16 1.36 to 3.45 0.001 0.10
Ajusted* 333 676 2.03 1.09 to 3.78 0.026 0.07
Data described as geometric mean; GMR: geometric mean ratio of non-smokers
to smokers representing the relative difference or fold change; η2: Eta square
(ANCOVA’s measure of effect size); *variables included in the model were age,
sex, education, BMI, alcohol intake, and regular weekly physical activity
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DHA may improve cognitive ability and facilitate synap-
tic plasticity [15]. The improvement of such abilities is
linked to a decreased risk of neurological and psychiatric
illnesses, another possible link to the inverse relationship
between smoking and omega-3 intake [32, 33].
As a consequence of any one of these mechanisms,
the lower concentrations of omega-3 PUFAs could affect
neurotransmission in several ways in the central nervous
system. The ultimate result would be an affected reward
response and nicotine dependence, increasing cigarette
cravings and frustrating smoking cessation attempts.
In accordance with such a possibility, a previous study
has shown a daily supplement of EPA and DHA for
smokers has been accompanied by a significant decrease
in the number of daily cigarettes smoked and in tobacco
craving episodes [11]. However, in another trial, DHA
supplementation given to a small number of smokers for
only a few weeks, in a low dosage, without a control
group did not show reduction in the number of smoked
cigarettes during the treatment period [19].
There is a group of foods that brings health benefits
beyond the traditional nutritional functions. They are
now labeled as functional foods. When a product is puri-
fied from foods and sold as in medicinal forms for health
benefits it is called nutraceuticals. Under this perspective
fish oils and omega-3 are under research and several pa-
pers have been published demonstrating their efficacy in
protecting cardiovascular system and thus reducing the
risk of many cardiovascular diseases [31].
However, such relationship between the nutraceutical
omega-3 and smoking status is only beginning to be ex-
amined. In the present study, we detected a small, but
significant difference in the omega-3 index between the
group of smokers and non-smokers. The importance of
this finding is unknown at this moment and needs to
better evaluation.
Some limitations to our study should be noted. The
major one is that, as a cross-sectional study, it does not
provide any indication of the sequence of events, whether
exposure occurred before, after or during the onset of the
outcome. Second, we recruited control subjects from the
general population via press advertisements. However, they
were all Caucasian and lived in Toronto, Canada. Anyway
we realize that these individuals might have different life-
styles compared to the individuals in our smoking group.
Nonetheless, the reported relationships between smoking
and lower DHA concentrations persisted, even after the
adjustment modelling. Third, since we gathered dietary
data via self-reported questionnaires and we did not verify
the consumption directly, recall bias may have occurred.
Fourth, we examined only Caucasian volunteers, which
limit the generalizability of our results to other population
groups that typically eat more fish, such as Asian popula-
tions [34, 35].
Although the sample seems small, statistical calcula-
tion was previously performed to be enough to answer
the study questions, having 90 % statistical power and
effect size ≥ 0.5 with significance level α = 0.05. Anyway,
probably it would be necessary a larger sample to study
the relationship between omega-3 RBC content and
tobacco load expressed as pack-years. We detected an
inverse trend, but not statistically significant, that is, the
more the subject smoked, the lower was his or her
omega-3 content. Similarly, not significant findings were
detected in the relationship of monthly fish intake and
the level of nicotine dependence, as measured by the
Fagerstrom test.
Conclusions
Our results add some aspects to clarify the importance
of omega-3 intake in smoking behavior. The finding that
smokers consume less fish rich in omega-3 fatty acids
compared to nonsmokers is in agreement with their
lower levels of DHA and EPA. We believe that these
findings adjusting for food intake have not been yet
demonstrated nor the intake qualitative differences.
Omega-3 studies that include smokers and non-smokers
must consider differences in unsaturated fatty acids
intake. Future studies will be needed to determine the
reason(s) for these dietary differences.
Considering that the food intake pattern is a change-
able behavior, it is possible that an increase in fish con-
sumption or DHA supplementation may have a role in
smoking prevention or as an adjuvant in treatment of to-
bacco dependence [10]. We believe that this hypothesis
deserves further studies.
Methods
Using a cross-sectional design, we recruited current
smokers, trying to quit (group I) screened at the Toronto
Western Hospital and at the Centre for Addiction and
Mental Health, both in Toronto, Canada. Non-smokers
(group II) were recruited from the local community by
press advertising. These subjects were included in the
study from January to December 2013.
Table 4 Fish consumption rates in smokers and non-smokers
Fish Smokers n = 50 Nonsmokers n = 50 P
Only salmon 14 (28.0) 26 (52.0) 0.025
Trout 2 (4.0) 5 (10.0) 0.44
Tuna 8 (16.0) 8 (16.0) 0.99
Haddock 2 (4.0) 3 (6.0) 0.88
Tilapia 3 (6.0) 4 (8.0) 0.91
Others 7 (14.0) 16 (32.0) 0.057
>1 type 14 (28.0) 15 (30.0) 0.99
Data presented as counts of subjects: n (%)
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Caucasian men and women, aged 18–75 years were
eligible to participate if they agreed to the study proce-
dures. Exclusion criteria were refusal to sign the consent
form, use of omega-3 supplements, illiteracy, inability to
understand the study procedures, a strict vegetarian diet,
pregnancy or nursing mothers, drug abuse, currently un-
stable diseases, including mental illnesses and any regu-
lar pharmacological treatment.
At the first interview, the participants were informed
about the objectives and procedures of study and signed a
written consent form. A trained registered nurse (author
NS) interviewed and examined all participants at the same
time of the day (early morning, around 8:00 AM).
Information related to demographic data, education
level, alcohol consumption and level of physical activity
via self-reports were collect. The subjects were asked to
complete a part of a previously validated Food Frequency
Questionnaire [36]. Such section of the questionnaire
contains specific questions about intake of fish and
seafood in general and also about the intake of other foods
rich in omega-3.
Patients filled out the questionnaire considering a
monthly food record frequency. In order to facilitate the
identification of the size of the food portions, photos
and replicas of the foods and dishes were shown to the
participants.
Lifestyle habits data (alcohol intake and physical activ-
ity) were also obtained at the same interview, as possible
confounding factors [20, 28]. The volunteers were
categorized as alcohol non-drinkers (<180 g/week) or
drinkers (≥180 g/week) [28]. We considered regular
physical activity when the volunteer performed at least
a ≥ 30 min session per week.
Regarding smoking, the subjects were classified into
two groups: current smokers and non-smokers. Current
smokers were individuals who had smoked ≥100 ciga-
rettes in their lifetime and were still smoking daily or
most days. Subjects who had smoked < 100 cigarettes in
their lifetime were excluded. Non-smokers were individ-
uals who have never smoked. Among the smokers, the
exposure was quantified in pack years, where one pack
year is 20 cigarettes smoked/day for one year. It was cal-
culated multiplying the number of cigarette packs
smoked per day by the number of years the person
smoked [37]. All smoking patients also performed the
Fagerström Test for Nicotine Dependence (FTND) [27].
Height and weight were recorded and a blood sample
of the fasting patient was drawn and conducted around
the same time for all participants (early morning, around
8:00 AM).
The American Heart Association recommends the con-
sumption of two servings of fish per week for persons with
no history of coronary heart disease and at least one
serving of fish daily for those with known coronary heart
disease, assuming that a serving size is approximately 99
grams [5].
The PUFAs here studied (alpha-linolenic, eicosapenta-
enoic, docosapentaenoic and docosahexaenoic acids)
were measured in the RBC membranes and the levels
may vary with diet and be altered by specific supplemen-
tation [26].. So, the blood sample was collected early in
the morning in fasting patients. The lab tests were car-
ried out at the Laboratory of Clinical Analysis of the
University of Guelph, in the city of Guelph, Canada.
Blood samples were taken in 4 ml test tubes containing
EDTA and were centrifuged (910G for 10 minutes) to
separate the red cells from the plasma. Next, the cells
were frozen at -80 °C. Each sample was taken, saponified
and transmethylation was performed using a 6890 Chro-
matograph (Supelco, Bellefonte, Pennsylvania, USA).
The results were given as a percentage of the total fatty
acid composition.
Statistical analysis
The sample size of 100 subjects (at least 50 in each group)
was previously calculated to have a 90 % statistical power
and effect size ≥ 0.5 and significance level α = 0.05. The
categorical data are presented as counts and percentages.
The continuous variables are described by means and
standard deviations or by medians and ranges when the
distributional assumptions were in doubt. A standard de-
viation greater than half of the value of the respective
mean was the criterion for data normality analysis. We
used the Chi-square test or Fisher’s exact test to compare
the categorical data. For the initial comparison of the quan-
titative data, we used Student’s t-test to compare the means
and the Mann-Whitney U test to compare the medians.
We conducted an adjusted comparison between smokers
and nonsmokers using the analysis of covariance model
(ANCOVA) including age, sex, education, body mass index
(BMI), alcohol consumption and physical activity. The
inclusion of factors in the ANCOVA model was based on a
P-value threshold of 0.20 and an underlying conceptual
framework. Fish consumption (in grams per month) was
log transformed in order to minimize the impact of disrup-
tion of data normality assumptions. The data are presented
as geometric means and the relative difference between
current smokers and non-smokers are expressed using a
measure of fold change, the geometric mean ratio (GMR)
with 95 % confidence interval. The strength of the associ-
ation (effect size) between smoking and fish consumption
was also assessed using η2 (eta-square) model statistics
with an interpretation scale similar to r2 (Pearson’s linear
coefficient of determination).
The association between smoking and level of nicotine
dependence with fish consumption was evaluated using
Spearman’s correlation coefficient (rS).
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The statistical significance was set at α = 0.05 and the
data were analyzed using SPSS version 22.0.
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